Labroots is pleased to announce the 3rd annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2024. Immuno-Oncology is at the forefront of groundbreaking research in cancer therapeutics, widely hailed as one of the most promising frontiers in the battle against cancer. This cutting-edge field delves into the intricate interplay between the immune system and cancer cells to harness the body's natural defenses to combat cancer.
How our immune system can be mobilized to recognize and target cancerous cells is the focus of immuno-oncology. By understanding the body's immune response, immunotherapies can empower the immune system to identify and eliminate tumors with remarkable precision, offering new hope to patients facing various types of cancer.
Exploring the intricacies of immuno-oncology, the speakers and tracks in this virtual event series elucidate the remarkable strategies and therapies that promise to reshape the cancer treatment landscape.
This year's event includes the following tracks and topics:
Emerging Advances in Immuno-Oncology
Computational Approaches/AI
Microbiome and Metabolism in Cancer
Immunotherapies: Checkpoint Inhibitors, Engagers, and Vaccines
New Targets and Neoantigens
Cell Therapy: CARs, TCRs and Beyond
Translating Cancer Immunotherapies to the Clinic
Manufacturing of CAR T-Cell Therapy
In the dynamic landscape of immuno-oncology, various immunotherapies take center stage. These therapies exhibit the potential to function independently, collaboratively, or synergistically with other treatments, presenting a multifaceted approach to the formidable challenge of eradicating cancer.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2024 Immuno-Oncology Virtual Event Series. Submission is free. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global cell biology community with a high degree of interaction through live-streaming video and chat sessions.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.
Connect With Us!
When you attend the event remember to use the hashtag #LRimmuno to follow the conversation and connect with other members of the global Immunology and Oncology community!
Follow @Immunology_LR on Twitter and Labroots Immunology on Facebook to connect with our specialist Immunology Writers and stay up to date with the latest Trending News in Immunology!
Now, you can also join our professional community on LinkedIn! Check out the Microbiology and Immunology networking group on LinkedIn to meet others in your field and grow your network!
Associate Director of Ex Vivo Patient Tissue Platform, Crown Bioscience
Product Manager, Cell Culture Applications portfolio, GMP products, BioLegend
Postdoctoral Research Fellow, Genentech
Segment Marketing Manager, GenScript
Assistant Professor, Department of Aerospace and Mechanical Engineering, University of Notre Dame
Professor and Chair, Department of Bioengineering University of California, Los Angeles
Sr. Director, Application Sciences, Biognosys
VP of Sales, Alamar Biosciences
Senior Segment Marketing Manager- Antibody Drug Discovery, GenScript USA Inc.
Senior Scientist II, Crown Bioscience
The Vera Bradley Foundation Endowed Chair in Breast Cancer Innovation, Professor of Microbiology and Immunology, Director Brown Center for Immuno-Oncology and Vaccine Immunotherapy, The Indiana University School of Medicine, The Brown Center for Immunotherapy, The Simon Comprehensive Cancer Center
Chief Technology Officer, Alamar Biosciences
Principal Scientist, Emulate
Principal Investigator, Seattle Children's Research Institute, Assistant Professor, University of Washington School of Medicine
Senior Segment Marketing Manager, Cell Therapy, GenScript USA Inc.
Program Leader for CAR-T basic/translational research, Winship Center for Cancer Immunology, Assistant Professor of Hematology and Medical Oncology, Emory University School of Medicine
Assistant Professor of Pediatrics, Emory University, Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Junior Director of Graduate Studies, Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University
Assistant Professor of Medical and Molecular Genetics, Medical Sciences Program, Indiana University School of Medicine - Bloomington, Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Senior Product Scientist, Sino Biological
Senior RNA Synthesis Scientist, Shenzhen Yuanxing Gene-Tech Co., LTD
Eppendorf is a leading life science company that develops and sells systems for use in laboratories worldwide. Divided into the business units Liquid Handling, Consumables, Separation & Instrumentation, Bioprocess and Workflow Solutions, the product portfolio includes, for ...
See moreThe Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and ...
See moreSino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers ...
See moreCrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, inflammation, cardiovascular, and metabolic disease Drug Discovery. Our premier Translational Platforms for cancer ...
See moreWe are creating the most sensitive proteomics platform that can profile thousands of proteins simultaneously from as little as one microliter of plasma. Our fully automated, high throughput platform will unmask new biomarkers for early detection and prevention of common diseases ...
See moreThe speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Dr. Shannon Oda earned a Ph.D. in Immunology from the University of Colorado Anschutz Medical Campus and completed her postdoctoral training with Dr. Philip Greenberg at the Fred Hutchinson Cancer Research Center. She has received several awards, including the Evergreen Fund ...
See moreDr. Sandro Matosevic is an associate professor in the College of Pharmacy at Purdue University, and is a member of the Purdue Center for Cancer Research. Dr. Matosevic runs an NIH-funded research program focused on the development and use of cell-based therapies with natural ...
See moreRaoul S. Concepcion is the Chief Science Officer for U.S. Urology Partners in Nashville TN and Clinical Assistant Professor in the Department of Urology, Vanderbilt School of Medicine. Dr. Concepcion was a General Surgery and Urology Resident at Vanderbilt University School of ...
See moreJohn Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the Department of Biostatistics at the Harvard TH Chan School of Public Health and Professor at the Dana-Farber Cancer Institute. John's PhD was in Theoretical Physics but a fellowship to work ...
See moreDr. Curtis J. Henry received his Bachelor of Science degrees from Florida Agricultural and Mechanical University. He then matriculated into the graduate program at Wake Forest University School of Medicine and conducted research focusing on understanding how cytokines regulate ...
See moreKeith L. Knutson, Ph.D., is a consultant in the Department of Immunology, Mayo Clinic in Florida, where he also serves as director of the Discovery and Translation Lab's Cancer Research Program. Dr. Knutson joined the staff of Mayo Clinic in 2005 and holds the academic rank of ...
See moreMontserrat Valdes is a highly skilled chemical engineer with a diverse background in research and industry. She holds a Master of Science degree in Chemical Engineering from the University of Saskatchewan and an Analytical Chemistry Diploma from the National Autonomous University ...
See more